Literature DB >> 24619667

Pulsing dendritic cells with whole tumor cell lysates.

Laura Alaniz1, Manglio M Rizzo, Guillermo Mazzolini.   

Abstract

One of the strategies employed in immunotherapy for cancer is to use of ex vivo-generated dendritic cells (DC) pulsed with tumor antigens. Several approaches have been used to obtain and load tumor antigens in DC. One such technique is to use whole tumor cell lysate from one or more tumor cell lines of the tumor type to be treated. The advantage of applying this method is that it provides a large spectrum of tumor antigens. However, some considerations must be taken into account to obtain a lysate with appropriate biological activity, such as cell line harvest and the method to lyse the cells. In this chapter, we describe the steps to obtain whole tumor cell lysates from human tumor cell lines by repetitive freeze-thaw cycles in sufficient amount and quality to pulse DC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619667     DOI: 10.1007/978-1-4939-0345-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

2.  In vitro generation of cytotoxic T lymphocyte response using dendritic cell immunotherapy in osteosarcoma.

Authors:  Ye-Teng He; Qing-Min Zhang; Quan-Chun Kou; Bo Tang
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

3.  RAB8A a new biomarker for endometrial cancer?

Authors:  Yachun Bie; Zhenyu Zhang
Journal:  World J Surg Oncol       Date:  2014-12-04       Impact factor: 2.754

4.  High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity.

Authors:  Veronica M Ringel-Scaia; Natalie Beitel-White; Melvin F Lorenzo; Rebecca M Brock; Kathleen E Huie; Sheryl Coutermarsh-Ott; Kristin Eden; Dylan K McDaniel; Scott S Verbridge; John H Rossmeisl; Kenneth J Oestreich; Rafael V Davalos; Irving C Allen
Journal:  EBioMedicine       Date:  2019-05-23       Impact factor: 8.143

Review 5.  Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies.

Authors:  Carson R Reynolds; Son Tran; Mohit Jain; Aru Narendran
Journal:  Vaccines (Basel)       Date:  2022-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.